24/08/2025
NUEVA ESPERANZA EN EL TRATAMIENTO DEL ALZHEIMER
https://www.medscape.com/viewarticle/experimental-med-tied-slowed-alzheimers-biomarker-2025a1000lo8?ecd=soc_fb_250824_mscpedt_news_mdscp_&fbclid=IwQ0xDSwMYQHtleHRuA2FlbQIxMQABHuRmtkIGTQFkpfVfXWMOkCAR12r741DccH0oIz8GgOwMKh8_wMXCVD-aweOZ_aem_J_qgknHdDGm3psYvACPhvg
The experimental cholesterol drug obicetrapib slowed Alzheimer’s biomarkers, over 12 months in patients with cardiovascular disease, offering a potential new therapy.